Role of tumour markers in monitoring epithelial ovarian cancer
2000
Role of Tumour Markers in Monitoring Ovarian Cancer
publication
Evidence: moderate
Author Information
Author(s): Meyer T, Rustin G J S
Primary Institution: Department of Medical Oncology, Mount Vernon Hospital
Conclusion
CA125 is the only tumour marker with a well-defined role in managing ovarian cancer, indicating response or progression, but its use in diagnosis or prognosis is not yet clear.
Supporting Evidence
- CA125 is currently the only tumour marker with a well-defined role in ovarian cancer management.
- Changes in CA125 levels can indicate treatment response or disease progression.
Takeaway
Doctors can use a blood test called CA125 to see how well treatment is working for ovarian cancer, but it's not good for finding out if someone has cancer.
Limitations
Other tumour markers are still experimental and not yet useful.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website